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Abstract 
The YAHSGS LLC and Oak Ridge National Laboratory established a CRADA to develop a 
computational neural network and wavelets software to facilitate providing national needs for 
toxicity prediction and overcome the voracious drain of resources (money and time) being 
directed to the development of pharmaceutical agents. The research project was supported 
through a STTR Phase I task by NIEHS in 2004. The research deploys state-of-the-art 
computational neural networks and wavelets to make toxicity prediction on three independent 
bases: (I) quantitative structure-activity relationships, (2) microarray data, and (3) Massively 
Parallel Signature Sequencing technology. Upon completion of Phase I, a prototype software 
Multi-Intelligent System for Toxicogenomic and Applications (MISTA) was developed, the 
utility's feasibility was demonstrated, and a Phase I1 proposal was jointly prepared and submitted 
to NIEHS for hnding evaluation. The goals and objectives of the program have been achieved. 
Statement of Objectives 
There is a critical need for inexpensive nonclinical methods to achieve rapid and accurate 
prediction of toxicity of potential drugs and environmental agents. Development and testing of 
new pharmaceuticals frequently require 12 to 15 years, with investment exceeding $500 million 
per drug and expenditures averaging over $1 50 million for drugs that fail during testing 
(Blackwell 2001). The CRADA No. ORNL-04-0688 with YAHSGS LLC is focused on the 
national need for toxicity-prediction capability and for overcoming the failures of drug 
development. The research deploys computational neural networks (CNNs) and wavelets to 
make toxicity prediction on three independent bases: (1) quantitative structure-activity 
relationships (QSAR), (2) microarray data, and (3) Massively Parallel Signature Sequencing 
(MPSS) technology. A research and development tool, the Multi-Intelligent System for 
Toxicogenomic and Applications (MISTA), will be developed and its feasibility tested in the 
Phase I performance period. 
Specific research aims are: 
1. Adapt QSAR-based software to function within MISTA's structure, access a web-based 
data-management structure that integrates existing and new data to support MISTA 
project data-management requirements, and make toxicological endpoint predictions. 
2. Demonstrate the feasibility of developing multi-intelligent algorithms that analyze and 
utilize microarray test data for toxicogenomic predictions. 
3. Demonstrate the feasibility of developing multi-intelligent algorithms that analyze and 
utilize MPSS data to enhance our toxicogenomic prediction capability. 
4. Demonstrate the feasibility of the overall integrated system to make accurate predictions 
of chemical action on a selected target organ (liver) by challenging it with known and 
interpreted test results and studies elucidating the genotoxic effects of chemicals. 
Benefits to the Funding DOE Office's Mission 
The STTR Phase I research was supported by the National Institute of Environmental 
Health Sciences (NIEHS). By way of this CRADA, ORNL and YAHSGS LLC will enhance the 
mission of DOE' Ofice of Science by collaborating to produce a software product that will help 
manage the huge volumes of genomic data generated through the Human Genome Project and 
the Genomes to Life Program. 
Technical Discussion of Work Performed by All Parties 
Tasks in which ORNL will participate: 
1. Determined feasibility of applying ORNL Neural Net and Wavelet software to evaluate 
chemical effects on the genomes of single or multiple organisms, focusing on genes of 
significance to liver toxicity and chemicals from classes of concern to human health. 
2. Developed and adapted algorithms for predicting genetic effects of chemical actions and 
for understanding the significance of these interactions and how these toxicological 
events lead to specific disease states. 
3. Integrated YAHSGS advanced structure-toxicity modules to simultaneously predict 
chemical toxicity independent of microarray data, using a prototype to demonstrate the 
system's applicability by challenging it with microarray test results. 
4. Created a web-based structure to store and use project data, with features that promote 
efficient receipt and exchange of information from linked researchers. 
Tasks in which YAHSGS will participate: 
1. Led project's overall technical and administrative management. 
2. Evaluated toxicity data for the MISTA database. 
3. Prepared and submit Phase I1 proposal to NIEHS. 
4. Explored marketing possibilities and strategies. 
Project Accomplishments 
Upon completion of Phase I, two draft papers were prepared for open publication: 
1 .  Sumpter, B.G., Nois, D.W., Lu, P.Y., Brothers, R., and Wassom, J.S. 2005. "An 
Integrated Toxicity Evaluation and Predictive System Based on Neural Networks and 
Wavelets." 
2. Sumpter, B.G., Nois, D.W., Lu, P.Y., Brothers, R., and Wassom, J.S. 2005. 
"Computational Molecular Toxicology: A Chemical and Materials Toxicity Evaluation 
Module (CAMTEM)." 
Comn~ercialization Possibilities 
A user-friendly database that manages microarray data on chemical agents evaluated for liver 
toxicity was developed (MISTA Database) to support the LiverTox software that predicts 
activity of chemicals evaluated for gene-expression effects in the liver. The prototype database 
can be further developed for a commercial product in the future. 
Plans for Future Collaboration 
Upon completion of Phase I, YAHSGS LLC and ORNL worked together to prepare a Phase I1 
proposal to continue development of the LiverTox system, which applies advanced QSAR and 
toxicogenomic software for hepatotoxicity prediction. Specific research aims are: 
1. Enhance and verify data-module interfaces. 
2. Enhance and verify CNN Microarray Module. 
3. Complete, train, and test MPSS Module. 
4. Complete, train, and test Proteomic Module. 
5 .  Complete, train, test Metabonomic-Metabolomic Module. 
6. Complete and train MISTA for multimodule integrated liver-toxicity predictions. 
Conclusions 
A productive collaboration between ORNL and YAHSGS LLC during Phase I of the CRADA 
produced a prototype computing neural network software titled "LiverTox: Advanced QSAR and 
Toxicogenomic Software for Hepatotoxicity Prediction." A follow-on Phase I1 CRADA 
proposal has been jointly prepared and submitted to NIEHS for evaluation. 
